Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Two of three patients with multiple chemical sensitivity had less symptoms and secondary hyperalgesia after transcranially applied pulsed electromagnetic fields

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Chronic pain after bilateral thoracotomy in lung transplant patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prescribed opioid analgesic use developments in three Nordic countries, 2006-2017

    Research output: Contribution to journalReviewResearchpeer-review

  1. Itch sensitization? A systematic review of studies using quantitative sensory testing in patients with chronic itch

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Classification and treatment of itch

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Assessing Punctate Administration of Beta-alanine as a Potential Human Model of Non-histaminergic Itch

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Alloknesis and hyperknesis-mechanisms, assessment methodology, and clinical implications of itch sensitization

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background Multiple chemical sensitivity (MCS) is a chronic, disabling condition characterized by recurrent multisystem symptoms triggered by common airborne chemicals. Evidence points towards abnormal sensory processing in the central nervous system (CNS) as a likely pathophysiological mechanism. No effective treatment has yet been reported, but clinical observations suggest that as pulsed electromagnetic fields (PEMF) is a treatment for some CNS disorders (depression and chronic pain), it may also be a treatment modality for MCS. Methods In an open case study, the effects of PEMF were assessed in three MCS patients. All cases received 30 min daily treatment 5 days a week for 8 consecutive weeks. Symptoms and functional impairments related to MCS, depressive symptoms, and capsaicin-induced secondary punctate hyperalgesia were assessed at baseline and weekly until an 18-week follow-up. Results Two of the three cases showed considerable improvement on all measures of symptoms and functional impairments related to MCS in response to PEMF therapy. One case showed no improvement and during the treatment period was unexpectedly diagnosed with depression. Conclusion Our findings indicate potential benefits of PEMF therapy in MCS. Implication The therapeutic effect of PEMF in MCS needs to be investigated by a randomized placebo-controlled trial.

Original languageEnglish
JournalScandinavian Journal of Pain
Volume5
Issue number2
Pages (from-to)104-109
Number of pages6
ISSN1877-8860
DOIs
Publication statusPublished - 1 Apr 2014

ID: 55209995